-
-
Overview
-
Please contact us at for specific academic pricing.
Background
Avermectin B1 is a mixture of avermectins containing >80% avermectin B1a and <20% avermectin B1b. B1a and B1b have very similar biological and toxicological properties.
In vitro: The avermectins are insecticidal and antihelmintic compounds derived from various laboratory broths fermented by the soil bacterium. Avermectin B1 is a natural fermentation product of this bacterium.
In vivo: Avermectin B1 therapy resulted in significant decreases in mean strongyle egg after treatment. All horses given ivermectin or avermectin B1 had zero strongyle egg counts 14 and 28 d after treatment. The oral administration of avermectin B1 appeared to be highly efficacious against intestinal strongyles and Onchocera microfilaria [1].
Clinical trial: Currently no clinical data are available[1] Mogg TD, Pollitt CC, Willmore JP, Thompson H. Efficacy of avermectin B1 given orally against equine intestinal strongyles and Onchocera microfilaria. Aust Vet J. 1990;67(11):399-401.
-
- Properties
-
Overview